This document contains 11 references related to phenytoin-induced gingival overgrowth. The references discuss the characteristics of epilepsy cases in Indonesia, compliance with epilepsy medication therapy in children, increasing detection of epilepsy in Indonesia, molecular and immune features of phenytoin-induced gingival overgrowth, management of phenytoin-induced gingival enlargement through a case report, correlation between serum levels of antiepileptic drugs and their side effects, and the etiopathogenesis of phenytoin-induced gingival enlargement.
This document contains 11 references related to phenytoin-induced gingival overgrowth. The references discuss the characteristics of epilepsy cases in Indonesia, compliance with epilepsy medication therapy in children, increasing detection of epilepsy in Indonesia, molecular and immune features of phenytoin-induced gingival overgrowth, management of phenytoin-induced gingival enlargement through a case report, correlation between serum levels of antiepileptic drugs and their side effects, and the etiopathogenesis of phenytoin-induced gingival enlargement.
This document contains 11 references related to phenytoin-induced gingival overgrowth. The references discuss the characteristics of epilepsy cases in Indonesia, compliance with epilepsy medication therapy in children, increasing detection of epilepsy in Indonesia, molecular and immune features of phenytoin-induced gingival overgrowth, management of phenytoin-induced gingival enlargement through a case report, correlation between serum levels of antiepileptic drugs and their side effects, and the etiopathogenesis of phenytoin-induced gingival enlargement.
This document contains 11 references related to phenytoin-induced gingival overgrowth. The references discuss the characteristics of epilepsy cases in Indonesia, compliance with epilepsy medication therapy in children, increasing detection of epilepsy in Indonesia, molecular and immune features of phenytoin-induced gingival overgrowth, management of phenytoin-induced gingival enlargement through a case report, correlation between serum levels of antiepileptic drugs and their side effects, and the etiopathogenesis of phenytoin-induced gingival enlargement.
1. Tjandrajani A, Widjaja JA, Dewanti A et al. Karakteristik kasus epilepsi di
Rumah Sakit Anak dan Bunda Harapan Kita pada tahun 2008-2010. Sari Pediatri. 2012. 14(3):143-146 2. Pinzon R. Profil kepatuhan terhadap program terapi obat pada epilepsi onset anak-anak. Medicinus. 2011. 24(1):25-28 3. Kartika U. Penyakit epilepsi makin banyak terdeteksi. 2013. [18 Juli 2013]. http://health.kompas.com/read/2013/06/27/1730364/Penyakit.Epilepsi.Makin. Banyak.Terdeteksi 4. Albinsaid G. Epilepsi. [18 Juli 2014]; http://kesehatan.kompasiana.com/medis/2013/05/19/epilepsi-557529.html 5. Correa JD, Junior CMQ, Costa JE et al. Phenytoin-induced gingival overgrowth: A Review of the molecular, immune, and inflammatory features. International Scholarly Research Network Dentistry. 2011. 2011:1-8 6. Parwani RN, Parwani SR. Management of phenytoin-induced gingival enlargement: a case report. General Dentistry. 2013:61-67 7. Marakoglu I, Gursoy UV, Cakmak H, et al. Phenytoin-induced gingival overgrowth in un-cooperated epilepsy patients. Yonsei Medical Journal. 2004. 45(2):337-340 8. Gautam A, Verma PK, Srivastava R et al. Esthetic correction of phenytoin induced gingival hyperplasia-case reports. Health Care. 2013. 1(2):28-31 9. Gosavi DD, Akanksha S, Sanjay N. A case of phenytoin induced gum enlargement. Asian Journal of Pharmaceutical and Clinical Research. 2012. 5(1):1-2 10. Hussein A, Abdulgalil A, Omer F et al. Correlation between serum level of antiepileptic drugs and their side effects. Oman Medical Journal. 2010. 25(1):1-5 11. Nayyar AS. Phenytoin and gingival enlargement: A brief overview of etiopathogenesis. International Journal of Health Sciences and Research. 2012. 2(1):127-134